Pingyong Yi

Changsha Central Hospital — China

Medicine · Health Sciences

12h-index597citations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(14), Viral-associated cancers and disorders(6), Immunotherapy and Immune Responses(5), Monoclonal and Polyclonal Antibodies Research(4), Immune Cell Function and Interaction(3)

Publications26 total

GPI: An indicator for immune infiltrates and prognosis of human breast cancer from a comprehensive analysis
Frontiers in Endocrinology·2022· 16 citedOpen Access
Inhibitory effect of PI3Kδ inhibitor idelalisib on proliferation of human myeloid leukemia cells and the reversal effect on drug resistance to adriamycin.
PubMed·2020
A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma
Frontiers in Endocrinology·2020· 23 citedOpen Access
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2 <sup>+</sup> Breast Cancer Cells to 5-Fluorouracil
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics·2020· 17 citedOpen Access
Pyrotinib sensitizes 5‑fluorouracil‑resistant HER2-positive breast cancer cells to 5‑fluorouracil
Research Square (Research Square)·2020· 2 citedOpen Access
A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
Journal of Hematology & Oncology·2020· 50 citedOpen Access
HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases
Blood Research·2020· 45 citedOpen Access
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group
Leukemia·2020· 58 citedOpen Access
Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients
Medical Science Monitor·2019· 24 citedOpen Access
A proposal for a new staging system for extranodal natural killer T-cell lymphoma, nasal type, to predict the treatment strategy: A multicentre study from the Chinese Southwest Oncology Group and Asia Lymphoma Study Group.
Journal of Clinical Oncology·2018
Short-Course Versus Long-Course Chemoradiotherapy for Stage IE–IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study
Medical Science Monitor·2018· 4 citedOpen Access
Retraction notice to “BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma” [Biochem. Biophys. Res. Commun. 491 (2017) 939-945]
Biochemical and Biophysical Research Communications·2018· 3 cited
A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Journal of Cancer·2018· 14 citedOpen Access
Efficacy and tolerance of <scp>GELOXD</scp>/P‐<scp>GEMOXD</scp> in newly diagnosed nasal‐type extranodal <scp>NK</scp>/T‐cell lymphoma: A multicenter retrospective study
European Journal Of Haematology·2017· 27 cited
Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study
Chinese Journal of Cancer·2017· 8 citedOpen Access
RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma
Biochemical and Biophysical Research Communications·2017· 2 cited
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Journal of Hematology & Oncology·2017· 245 citedOpen Access
ALDH1A1 mediates resistance of diffuse large B cell lymphoma to the CHOP regimen
Tumor Biology·2014· 25 cited
[Clinical analysis of 82 cases of primary mediastinal large B cell lymphoma].
PubMed·2014
Relationship between loss of heterozygosity of deleted in colorectal carcinoma gene microsatellites and prognosis of colorectal adenocarcinoma
World Journal of Gastroenterology·2011· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

J Y Li(6), Meizuo Zhong(5), Wenxue Ma(5), Yajun Li(4), Kunlun Li(4), Jianing Yi(4), Jinghua Wang(3), Mingzhi Zhang(3), Xianling Liu(3), Hanjia Luo(3), Lianhong Zou(3), Changxin Huang(3), Hai Yu(3), Yuankai Shi(2), Ting Liu(2), Huilai Zhang(2), Haiyan Yang(2), Zhengming Jin(2), Jianmin Yang(2), Hang Su(2)